...
首页> 外文期刊>International Urology and Nephrology >Treatment trends, determinants, and survival of partial and radical nephrectomy for stage I renal cell carcinoma: results from the National Cancer Data Base, 2004–2013
【24h】

Treatment trends, determinants, and survival of partial and radical nephrectomy for stage I renal cell carcinoma: results from the National Cancer Data Base, 2004–2013

机译:治疗趋势,决定因素和分期性肾细胞癌的部分和自由基肾切除术的生存:国家癌症数据库的结果,2004 - 2013年

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Abstract Objective To provide updated treatment trends, determinants, and survival of partial nephrectomy (PN) and radical nephrectomy (RN) across the USA. Data sources Secondary data from the National Cancer Data Base (NCDB) participant user file from 2004 to 2013. The NCDB captures approximately 70% of all newly diagnosed cancer cases each year. Study design Multivariable logistic regression was used to estimate odds ratios for RN overall. Kaplan–Meier, multivariable Cox regression, and log-rank test were used to characterize patient survival. Data collection Patients diagnosed with clinical stage I RCC who received either RN or PN as the primary surgical treatment were included. Principle findings The study consisted of 121,386 cases (PN?=?57,016; RN?=?64,370). The overall use of PN for stage I RCC increased by 24.2% over 9?years. An overall 5- and 10-year survival advantage was estimated following PN compared to RN; estimated overall risk of death was higher with RN. Conclusions The use of PN for stage I RCC has continued to increase and is associated with an overall survival advantage. Multivariable analysis showed that disparities exist among sociodemographic groups that are also associated with treatment type and survival.
机译:摘要目的提供最新的治疗趋势,决定因素和美国部分肾切除术(PN)和激进的肾病(RN)的生存。数据源来自2004年至2013年的国家癌症数据库(NCDB)参与者用户文件的二级数据。NCDB每年捕获所有新诊断癌症病例的70%。研究设计多变量逻辑回归用于估计整体RN的差距比率。 Kaplan-Meier,多变量的Cox回归和对数秩检验用于表征患者生存。诊断患有作为主要手术治疗的临床阶段I RCC诊断的数据收集患者。原理发现该研究包括121,386例(PN?=?57,016; rn?=?64,370)。 PN阶段I型RCC的整体使用增加了24.2%以上超过9倍。与RN相比,PN估计了整体5-和10年的存活优势;估计死亡的总体风险较高,RN较高。结论使用PN阶段I RCC的使用持续增加,与整体生存优势有关。多变量分析表明,与治疗类型和生存相关的同期存在差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号